Albemarle Corporation (NYSE:ALB – Free Report) – Research analysts at Scotiabank issued their Q3 2026 EPS estimates for Albemarle in a research report issued on Monday, August 10th. Scotiabank analyst B. Isaacson forecasts that the specialty chemicals company will post earnings per share of $2.67 for the quarter. Scotiabank currently has a “Sector Outperform” rating and a $190.00 target price on the stock. The consensus estimate for Albemarle’s current full-year earnings is $12.73 per share.
Albemarle (NYSE:ALB – Get Free Report) last announced its earnings results on Wednesday, August 5th. The specialty chemicals company reported $3.75 EPS for the quarter, topping the consensus estimate of $3.20 by $0.55. The business had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.61 billion. Albemarle had a net margin of 3.09% and a return on equity of 10.96%. The firm’s revenue was up 31.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.11 earnings per share.
Albemarle Trading Up 0.1%
Shares of NYSE:ALB opened at $131.29 on Tuesday. The company’s 50-day moving average price is $136.81 and its two-hundred day moving average price is $163.79. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.09 and a quick ratio of 1.35. Albemarle has a one year low of $71.25 and a one year high of $221.00. The stock has a market capitalization of $15.49 billion, a PE ratio of 486.28 and a beta of 1.33.
Albemarle Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Friday, September 11th will be paid a dividend of $0.41 per share. This is an increase from Albemarle’s previous quarterly dividend of $0.41. This represents a $1.64 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Friday, September 11th. Albemarle’s dividend payout ratio is presently 600.00%.
Insider Transactions at Albemarle
In other Albemarle news, CEO J Kent Masters sold 16,393 shares of the stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $183.72, for a total value of $3,011,721.96. Following the sale, the chief executive officer directly owned 87,519 shares in the company, valued at $16,078,990.68. This represents a 15.78% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.42% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Albemarle
Large investors have recently added to or reduced their stakes in the business. Evexia Wealth LLC increased its position in shares of Albemarle by 2.3% in the first quarter. Evexia Wealth LLC now owns 2,088 shares of the specialty chemicals company’s stock worth $387,000 after purchasing an additional 47 shares during the last quarter. Parallel Advisors LLC grew its position in Albemarle by 2.5% in the fourth quarter. Parallel Advisors LLC now owns 2,468 shares of the specialty chemicals company’s stock worth $349,000 after acquiring an additional 60 shares in the last quarter. Eaton Financial Holdings Company LLC increased its stake in Albemarle by 1.2% in the fourth quarter. Eaton Financial Holdings Company LLC now owns 5,769 shares of the specialty chemicals company’s stock valued at $816,000 after acquiring an additional 66 shares during the last quarter. Sigma Planning Corp raised its position in Albemarle by 2.3% during the first quarter. Sigma Planning Corp now owns 2,952 shares of the specialty chemicals company’s stock valued at $530,000 after purchasing an additional 66 shares in the last quarter. Finally, Signature Estate & Investment Advisors LLC raised its position in Albemarle by 1.9% during the fourth quarter. Signature Estate & Investment Advisors LLC now owns 3,592 shares of the specialty chemicals company’s stock valued at $508,000 after purchasing an additional 67 shares in the last quarter. Institutional investors own 92.87% of the company’s stock.
About Albemarle
Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.
Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.
Read More
- Five stocks we like better than Albemarle
- China’s Athleisure Boom Is Not Lifting Every Brand Equally
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.
